Rational use of vasoactive drugs after cardiac resuscitation: focus on inotropic agents (Q34103368)

31 July 2017

1 reference

title

Rational use of vasoactive drugs after cardiac resuscitation: focus on inotropic agents (English)

1 reference

31 July 2017

1 reference

Girbes AR

1

1 reference

31 July 2017

publication date

1 November 2000

1 reference

31 July 2017

number of pages

4

1 reference

inferred from page(s)

published in

Resuscitation

1 reference

31 July 2017

volume

47

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

339-342

1 reference

A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. The Multicenter High-Dose Epinephrine Study Group

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

High-dose epinephrine in adult cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. European Epinephrine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

Cardiopulmonary resuscitation: historical perspective to recent investigations

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

Post-ischaemic organ dysfunction: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

Vasopressin improves vital organ blood flow after prolonged cardiac arrest with postcountershock pulseless electrical activity in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

Myocardial dysfunction after successful resuscitation from cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

Cardiovascular function during the postresuscitation phase after cardiac arrest in pigs: a comparison of epinephrine versus vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

Use of dopamine in the ICU. Hope, hype, belief and facts

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

Lack of specific renal haemodynamic effects of different doses of dopamine after infrarenal aortic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

Elevation of systemic oxygen delivery in the treatment of critically ill patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

Addition of enoximone to adrenergic agents in the management of severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

A study of the combined haemodynamic effects of dobutamine and enoximone in patients taking beta adrenoceptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

Epinephrine impairs splanchnic perfusion in septic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

Endobronchial vasopressin improves survival during cardiopulmonary resuscitation in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

L-NMMA (a Nitric Oxide Synthase Inhibitor) is Effective in the Treatment of Cardiogenic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9572%2800%2900325-7

7 January 2021

10.1016/S0300-9572(00)00325-7

Identifiers

DOI

1 reference

31 July 2017

1 reference